SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : anika research(anik) -- Ignore unavailable to you. Want to Upgrade?

To: Lou Cifer who wrote (150)8/13/1998 3:42:00 AM
From: chirodoc  Read Replies (1) | Respond to of 328
 
the odds of not getting approval are slim
the compound has a better side effect profile than approved competitiors
but if the approval was here, price would be 25 or higher
always a risk some jerk in the lab or prep committee rushes something and the FDA asks for more information
that will cause the stock to tank in tis environment
curtis



To: Lou Cifer who wrote (150)8/20/1998 4:55:00 PM
From: ZombieMike  Read Replies (2) | Respond to of 328
 
Come on back guys! Is anyone out there? Tremendous basing pattern on diminishing volume.

My guess is that all the sellers are gone. Stochastics would seem to support this idea as it enters oversold Normally, I would say this sucka is ready to explode. But, who knows in this market. I bought Ingram Micro last week on the same theory and got a $3 pop, but nothing since.

Options expire tommorrow. IMO, last chance to buy at thes prices is Fri a.m.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News